Genprex, Inc. Alternatives & Competitors

12 companies similar to Genprex, Inc. — Genprex is a gene therapy company focused on developing life-changing technologi...

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

11 Series B $44.40M

New Haven, United States

Biotechnology Health and Wellness +1

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

Seneca Therapeutics, Inc.

Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for...

10 Series B $9.09M

Philadelphia, United Stat...

Biopharma Biotechnology +3

Rival Readout

Competing with Genprex, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Lytix Biopharma

A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...

15 Grant $24.70M

Oslo, Norway

Biotechnology Health Care +1

Senex Biotechnology. Inc.

Preventing Adaptive Drug Resistance and Cancer Metastasis

5 Debt Financing $600.00K

Biotechnology Health and Wellness +1

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

Pacylex Pharmaceuticals, Inc.

A new target in cancer care - triggering selective lethality with a new class of drugs.

9 Grant $12.30M

Edmonton, Canada

Biotechnology Health Care +3

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology (Nasdaq: LIXT)

6 Post-IPO Equity $10.48M

United States

Biotechnology Health Care +1

ARIZ Precision Medicine

Targeting Cancer at the Root Cause

2 Seed $5.28M

Davis, United States

Biotechnology Health Care +1

SELLAS Life Sciences Group, Inc.

A late-stage clinical biopharmaceutical company focused on developing novel therapies for...

18 Post-IPO Equity $101.70M

New York, United States

Biopharma Biotechnology

Step Pharma

Developing selective inhibitors of CTPS1 for patients with cancer and auto-immune diseases

14 Series B $52.00M

France

Biotechnology Pharmaceutical

About Genprex, Inc.

Genprex is a biopharmaceutical startup founded in 2009, dedicated to pioneering life-altering therapies for cancer and diabetes through advanced gene therapy technologies. The company's innovative approach targets the delivery of disease-fighting genes, with the aim of creating new and effective treatment options for u...

Business keywords

Gene Therapy, Cancer Treatment, Diabetes Treatment, Clinical-stage Company, Disease-fighting Genes, Innovative Technology, Drug Candidates, Pipeline Development, Collaborative Partnerships

Frequently Asked Questions

Companies similar to Genprex, Inc. include Apollomics, Cybrexa Therapeutics, Prescient Therapeutics, Seneca Therapeutics, Inc., Lytix Biopharma. They work in Biotechnology and Pharmaceutical and share Genprex, Inc.'s focus on cancer treatment, drug candidates and gene therapy.

Bounce Watch lists 12 companies that share Genprex, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Genprex, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Genprex, Inc. Profile Apollomics Alternatives Cybrexa Therapeutics Alternatives Prescient Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Genprex, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.